| Dr Terry Lee Frederick, MD | |
|
2505 W Hamilton Rd S, Fort Wayne, IN 46814-9136 | |
| (260) 625-6200 | |
| (260) 625-6213 |
| Full Name | Dr Terry Lee Frederick |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 2505 W Hamilton Rd S, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508997248 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01024046A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Terry Lee Frederick, MD 2505 W Hamilton Rd S, Fort Wayne, IN 46814-9136 Ph: (260) 625-6200 | Dr Terry Lee Frederick, MD 2505 W Hamilton Rd S, Fort Wayne, IN 46814-9136 Ph: (260) 625-6200 |
News Archive
In a paper published today in Science Translational Medicine, researchers from Fred Hutchinson Cancer Research Center shared data from an early-phase study of patients with advanced non-Hodgkin lymphoma (NHL) who received JCAR014, a Chimeric Antigen Receptor (CAR) T cell treatment, and chemotherapy.
NIH-funded researchers at Stanford University used the gene editing tool CRISPR-Cas9 to rapidly identify genes in the human genome that might modify the severity of amyotrophic lateral sclerosis and frontotemporal dementia caused by mutations in a gene called C9orf72.
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) provide the first proof of concept data showing that a monoclonal antibody can neutralize human norovirus. This research, which could one day lead to effective therapies against the virus, was published online ahead of print in the Journal of Virology.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against the following question: "Based on the current available data, do you believe the overall benefit-risk assessment of PHEN/TPM (QNEXA) is favorable to support its approval for the treatment of obesity in individuals with a BMI > 30 kg/m2 or > 27 kg/m2 with weight-related co-morbidities?" The three co-morbidities included hypertension, diabetes and dyslipidemia.
› Verified 4 days ago
Rebecca Mason, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8233 Glencarin Blvd, Fort Wayne, IN 46804 Phone: 260-425-5470 Fax: 260-425-5475 | |
Anthony D Dennis, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 11635 Coldwater Rd, Fort Wayne, IN 46845 Phone: 260-637-1661 Fax: 260-637-1601 | |
Dr. Charles R Pattan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11050 Parkview Circle Dr, Fort Wayne, IN 46845 Phone: 833-724-8326 Fax: 260-266-8941 | |
Gregory L Chupp, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3909 New Vision Dr, Fort Wayne, IN 46845 Phone: 260-469-6610 | |
Christina Mcguirk, Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 2200 Randallia Dr, Fort Wayne, IN 46805 Phone: 260-373-4000 | |
Samantha Dawn Warden, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 750 Broadway Ste 350, Fort Wayne, IN 46802 Phone: 260-423-2675 Fax: 260-423-6621 | |
Dr. Mary Ann O'brien, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3909 New Vision Dr, Fort Wayne, IN 46845 Phone: 260-496-6602 Fax: 260-969-3065 |